<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04157764</url>
  </required_header>
  <id_info>
    <org_study_id>EMRP108057</org_study_id>
    <nct_id>NCT04157764</nct_id>
  </id_info>
  <brief_title>Improve Compliance in Automated Peritoneal Dialysis Machine With SHARESOURCE</brief_title>
  <official_title>The Impact of Telemonitoring on Compliance and Outcomes of Patients Undergoing Automated Peritoneal Dialysis With SHARESOURCE</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>E-DA Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>E-DA Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is to investigate the non-compliance rate of patients undergoing automated
      peritoneal dialysis by using automated peritoneal dialysis with SHARESOURCE software, and to
      evaluate if telemonitoring can improve peritoneal dialysis compliance and outcomes in the
      observation period.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The non-compliance of patients receiving automated peritoneal dialysis (APD) is around
      10-20%, and was believed to be under-estimated. Recently, a two-way telehealth system,
      SHARESOURCE software, provide practitioners real-time monitoring and recording of the therapy
      of APD.

      By using this APD with SHARESOURCE software, we want to investigate the non-compliance rate
      of patients undergoing automated peritoneal dialysis, want to see if it can improve
      peritoneal dialysis compliance and outcomes in the observation period.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">February 1, 2020</start_date>
  <completion_date type="Anticipated">January 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">January 31, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>use automated peritoneal dialysis machine without SHARESOURCE for 12 weeks, then use automated peritoneal dialysis machine with SHARESOURCE for 12 weeks</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change of baseline patients' non-compliance rate at 3 months</measure>
    <time_frame>baseline(between week 0 and 12) and 3 months(week 12 and week 24)</time_frame>
    <description>Non compliance rate was calculated by the days of non-compliance divided by days of APD therapy</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change of baseline peritoneal dialysis adequacy at 3 and 6 months</measure>
    <time_frame>baseline, week 12 and week 24</time_frame>
    <description>Dialysis adequacy is to see if dialysis is enough</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change of baseline uremic toxin level at 3 and 6 months</measure>
    <time_frame>baseline, week 12 and week 24</time_frame>
    <description>concentration of uremic toxins(ex: indoxyl sulfate, and p-cresyl sulfate)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>change of body composition analysis</measure>
    <time_frame>baseline, week 12 and week 24</time_frame>
    <description>body composition exam (Body Composition Monitor, Fresenius Medical Care, Bad Homburg, Germany) will be done</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>peritonitis rate (patient-month)</measure>
    <time_frame>follow up to week 60</time_frame>
    <description>calculate the number of peritonitis rate</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hospitalization rate</measure>
    <time_frame>follow up to week 60</time_frame>
    <description>calculate the number of hospitalization rate</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change of telephone contact frequency</measure>
    <time_frame>baseline(between week 0 and 12) and 3 months(week 12 and week 24)</time_frame>
    <description>the telephone contact frequency (from patient to nurse) for peritoneal dialysis-related problems will be collected</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Compliance, Patient</condition>
  <arm_group>
    <arm_group_label>APD</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>HomeChoice Claria APD machine with SHARESOURCE</intervention_name>
    <description>HomeChoice Claria APD machine with SHARESOURCE software. SHARESOURCE is a software can telemonitor patients' compliance</description>
    <arm_group_label>APD</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  stable received peritoneal dialysis for over 1 year. Use automated peritoneal dialysis
             machine regularly by him/herself.

        Exclusion Criteria:

          -  Acute hospitalization events due to acute coronary syndrome, stroke, heart failure,
             liver cirrhosis, systemic infection in 1 month.

          -  Life expectancy &lt;1 year

          -  Peritoneal dialysis prescriptions will be scheduled or expected to change in 3 months
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Shih-Yuan Hung</last_name>
    <phone>+8867-615-0011</phone>
    <phone_ext>2980</phone_ext>
    <email>ed100367@edah.org.tw</email>
  </overall_contact>
  <reference>
    <citation>Saran R, Robinson B, Abbott KC, Agodoa LYC, Bragg-Gresham J, Balkrishnan R, Bhave N, Dietrich X, Ding Z, Eggers PW, Gaipov A, Gillen D, Gipson D, Gu H, Guro P, Haggerty D, Han Y, He K, Herman W, Heung M, Hirth RA, Hsiung JT, Hutton D, Inoue A, Jacobsen SJ, Jin Y, Kalantar-Zadeh K, Kapke A, Kleine CE, Kovesdy CP, Krueter W, Kurtz V, Li Y, Liu S, Marroquin MV, McCullough K, Molnar MZ, Modi Z, Montez-Rath M, Moradi H, Morgenstern H, Mukhopadhyay P, Nallamothu B, Nguyen DV, Norris KC, O'Hare AM, Obi Y, Park C, Pearson J, Pisoni R, Potukuchi PK, Repeck K, Rhee CM, Schaubel DE, Schrager J, Selewski DT, Shamraj R, Shaw SF, Shi JM, Shieu M, Sim JJ, Soohoo M, Steffick D, Streja E, Sumida K, Kurella Tamura M, Tilea A, Turf M, Wang D, Weng W, Woodside KJ, Wyncott A, Xiang J, Xin X, Yin M, You AS, Zhang X, Zhou H, Shahinian V. US Renal Data System 2018 Annual Data Report: Epidemiology of Kidney Disease in the United States. Am J Kidney Dis. 2019 Mar;73(3 Suppl 1):A7-A8. doi: 10.1053/j.ajkd.2019.01.001. Epub 2019 Feb 21.</citation>
    <PMID>30798791</PMID>
  </reference>
  <reference>
    <citation>Bernardini J, Piraino B. Compliance in CAPD and CCPD patients as measured by supply inventories during home visits. Am J Kidney Dis. 1998 Jan;31(1):101-7.</citation>
    <PMID>9428459</PMID>
  </reference>
  <reference>
    <citation>The USRDS Dialysis Morbidity and Mortality Study: Wave 2. United States Renal Data System. Am J Kidney Dis. 1997 Aug;30(2 Suppl 1):S67-85.</citation>
    <PMID>9259694</PMID>
  </reference>
  <reference>
    <citation>Milan Manani S, Crepaldi C, Giuliani A, Virz√¨ GM, Garzotto F, Riello C, de Cal M, Rosner MH, Ronco C. Remote Monitoring of Automated Peritoneal Dialysis Improves Personalization of Dialytic Prescription and Patient's Independence. Blood Purif. 2018;46(2):111-117. doi: 10.1159/000487703. Epub 2018 Apr 25.</citation>
    <PMID>29694954</PMID>
  </reference>
  <reference>
    <citation>Uchiyama K, Washida N, Yube N, Kasai T, Shinozuka K, Morimoto K, Hishikawa A, Inoue H, Urai H, Hagiwara A, Fujii K, Wakino S, Deenitchina S, Itoh H. The impact of a remote monitoring system of healthcare resource consumption in patients on automated peritoneal dialysis (APD): A simulation study . Clin Nephrol. 2018 Nov;90(5):334-340. doi: 10.5414/CN109471.</citation>
    <PMID>30106369</PMID>
  </reference>
  <verification_date>November 2019</verification_date>
  <study_first_submitted>October 14, 2019</study_first_submitted>
  <study_first_submitted_qc>November 6, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">November 8, 2019</study_first_posted>
  <last_update_submitted>November 16, 2019</last_update_submitted>
  <last_update_submitted_qc>November 16, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">November 19, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Telehealth</keyword>
  <keyword>automated peritoneal dialysis</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

